Wojciech Kula

WORK HISTORY

EDUCATION

SKILLS

ABOUT WOJCIECH KULA

I founded Axcellant because I saw a gap in the CRO industry that needed filling.After nearly 20 years in clinical research, I noticed the same pattern: sponsors – especially small and mid-sized biotech and pharma companies – were underserved by large CROs. They needed senior expertise, transparent pricing, and genuine partnership. What they got was layers of project managers, opaque costs, and teams that rotated every few months.Axcellant is the CRO I wish had existed when I was on the sponsor side.We are a boutique, full-service Contract Research Organization with a global footprint – offices in New York and Warsaw, trial execution across Europe, the US, and APAC. We focus on therapeutic areas where innovation matters most: oncology, cardiology, rare diseases, and nuclear medicine.What makes us different is straightforward: lean teams of senior professionals who stay with your program from kickoff to regulatory submission. Full pricing transparency. Flexible engagement models. And a particular depth in nuclear medicine and imaging – including our own Imaging Core Lab capability.Our track record includes support for pharma companies, biotech startups, medical device manufacturers, and non-commercial research institutions. We handle everything from Phase I first-in-human studies to complex global registrational trials.Axcellant follows in the footsteps of ClinMed Pharma, a CRO I built that has served pharmaceutical and biotech companies since 2006.If you believe clinical research should be faster, smarter, and leaner – without cutting corners on quality or patient safety – I would welcome the conversation.Specialties: contract research organization (CRO) leadership, clinical trial management, nuclear medicine clinical trials, Imaging Core Lab, biotech partnerships, medical device clinical programs, regulatory submissions (FDA, EMA), global trial operations, boutique CRO model.